Ananiti-malaria drug touted by President Trump as a"game changer" for COVID-19 showed no benefit, according to an analysis of patients hospitalized in Veterans Health Administration medical centers.
The analysis found the two primary outcomes for people treated with hydroxychloroquine were death and the need for mechanical ventilation.
The analysis was conducted retrospectively, based on data from patients hospitalized with confirmed COVID-19 infections in all VA medical centers until April 11, 2020.
TVNL Comment: Read the second paragraph carefully. Self-anointed Dr. Trump is a charleton.
A company owned by two of Donald Trump’s top mega-donors has routinely brought dozens of its...
A Dec. 2 Instagram post (direct link, archive link) includes an image of a news headline...
A crack in a Colorado ski lift forced the evacuation of more than 170 stranded skiers...
On the brink of losing their supermajority in the state legislature, North Carolina Republicans overrode a...
